Dergiler / Turkish Journal of Pediatrics / 2020 / Cilt: 62 - Sayı: 4

Bee product efficacy in children with upper respiratory tract infections

Sayfa
634–640
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Bee products can be considered as a good treatment option because the available drugs already used for symptomatic treatment are not cost effective and can also have serious side effects in children.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background and objectives.
📊
Temel Bulgular & Veri:One hundred and four patients (59 male, 56.7%; 45 female, 43.3%) aged between 5‒12 years were included in the study.
💡
Sonuç & Katkı:Bee products can be considered as a good treatment option because the available drugs already used for symptomatic treatment are not cost effective and can also have serious side effects in children.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Background and objectives. The most common infectious disease in children is acute upper respiratory tract infection (URTI). Many drugs, especially antitussive drugs, are used for symptomatic treatment. Bee products (propolis, royal jelly, and honey) have antiviral, antibacterial, and antioxidant properties, and they have synergistic effects with antibiotics. The aim of this study was to evaluate the effectiveness of a mixture of bee products in URTI in children. Methods. The patients were divided into four groups consisting of two bacterial groups receiving either antibiotics or antibiotics + bee products and two viral groups treated with either placebo or bee products. Disease severity and improvement duration were assessed by the Canadian Acute Respiratory Illness and Flu Scale (CARIFS) Score. Results. One hundred and four patients (59 male, 56.7%; 45 female, 43.3%) aged between 5‒12 years were included in the study. Fifty patients (48%) were evaluated for bacterial infections and 54 (52%) for viral infections. Patients with viral infection receiving a mixture product showed earlier improvement, compared to placebo group. CARIFS scores were significantly lower in antibiotic + mixture group on day-2 and day-4, compared to antibiotic alone group (p <0.05). None of the patients developed any reactions or side effects to the mixture product. Conclusions. Bee products are effective in symptomatic treatment of upper respiratory tract infections. Bee products can be considered as a good treatment option because the available drugs already used for symptomatic treatment are not cost effective and can also have serious side effects in children.

🔖

Bu Makaleye Atıf Yap

SEÇİLMİŞ, Y., SİLİCİ, S. (2020). Bee product efficacy in children with upper respiratory tract infections. Turkish Journal of Pediatrics, Cilt: 62 - Sayı: 4, 634–640. https://ajindex.com/articles/411933

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Green RJ. Symptomatic treatment of upper respiratory tract symptoms in children. S Afr Fam Pract 2006; 48: 38-42
  2. Pappas DE, Hendley JO, Hayden FG, Winther B. Symptom profile of common colds in school-aged children. Pediatr Infect Dis J 2008; 27: 8-11
  3. Wessels MR. Streptococcal pharyngitis. N Engl J Med 2011; 364: 648-655
  4. Centers for Disease Control and Prevention (CDC). Infant deaths associated with cough and cold medications-- two states, 2005. MMWR Morb Mortal Wkly Rep 2007; 56: 1-4
  5. Sharfstein JM, North M, Serwint JR. Over the counter but no longer under the radar- pediatric cough and cold medications. N Engl J Med 2007; 357: 2321-2324
  6. Steinman MA, Landefeld CS, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA 2003; 289: 719-725
  7. Chlabicz S, Małgorzata-Ołtarzewska A, PytelKrolczuk B. Respiratory tract infections: Diagnosis and use of antibiotics by family physicians in northeastern Poland. Int J Antimicrob Agents 2004; 23: 446-450
  8. Pichichero ME. Understanding antibiotic overuse for respiratory tract infections in children. Pediatrics 1999; 104: 1384-1388
  9. Jacobs B, Young NL, Dick PT, et al. Canadian acute respiratory illness and flu scale (CARIFS): development of a valid measure for childhood respiratory infections. J Clin Epidemiol 2000; 53: 793-799
  10. World Health Organization (WHO). Cough and cold remedies for the treatment of acute respiratory infections in young children. 2001: 1-39. WHO reference number: WHO/FCH/CAH/01.02 11. Wahdan H. Causes of the antimicrobial activity of honey. Infection 1998; 26: 26-31
  11. Lusby PE, Coombes AL, Wilkinson JM. Bactericidal activity of different honeys against pathogenic bacteria. Arch Med Res 2005; 36: 464-467
  12. Finlay BB, Falkow S. Common themes in microbial pathogenicity. Microbiol Rev 1989; 53: 210-230
  13. Tamura Y, Kijima-Tanaka M, Aoki A, Ogikubo Y, Takahashi T. Reversible expression of motility and flagella in Clostridium chauvoei and their relationship to virulence. Microbiology 1995; 141(Pt 3): 605-610
  14. Paul IM, Beiler J, McMonagle A, Shaffer ML, Duda L, Berlin CM Jr. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161: 1140-1146
  15. Focht J, Hansen S, Nielsen JV, Van den Berg-Segers A, Riezler R. Bactericidal effect of propolis in vitro against agents causing upper res